Indian Pharmaceutical Association- Karnataka State Branch elects Dr M Khalid Khan as president: Our Bureau, Bengaluru ...
Neurocrine Biosciences begins phase 3 registrational study of osavampator as an adjunctive therapy to treat major depressive disorder: San Diego Wednesday, January 29, 2025, 18:00 ...
GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...
EMA accepts for review regulatory application of GSK’s Shingrix new prefilled syringe presentation for prevention of shingles: London, UK Wednesday, January 29, 2025, 13:00 Hrs ...
Curium introduces innovative 18F-PSMA PET radiopharmaceutical, Pylclari to treat prostate cancer in Estonia, Finland, Latvia, & Sweden: Paris, France Wednesday, January 29, 2025, ...
Lytus Technologies launches ‘Lytus HealthTech’ to address growing challenges in the country's healthcare system: Our Bureau, Chennai Wednesday, January 29, 2025, 13:30 Hrs [IS ...
Lifesigns and AIIMS to transform patient monitoring with advanced technology at Maha Kumbh Mela 2025: Our Bureau, Bengaluru Wednesday, January 29, 2025, 15:15 Hrs [IST] Lifesigns, ...
Beckman Coulter receives US FDA breakthrough device designation for Alzheimer’s disease blood test: Brea, California Wednesday, January 29, 2025, 16:00 Hrs [IST] Beckman Coulter ...
Neurocrine Biosciences, Inc., is a leading neuroscience-focused, biopharmaceutical company, announced it has amended its agreement with Takeda to develop and commercialize osavampator (NBI-1065845/TAK ...
OneSource in Q3FY25 clocked revenues of Rs. 392.6 crore with 18% growth: Our Bureau, Bengaluru Wednesday, January 29, 2025, 12:45 Hrs [IST] OneSource Specialty Pharma formerly kno ...
Intuitive appoints Rohitt Mahajan as vice president and general manager in India: Our Bureau, Bengaluru Wednesday, January 29, 2025, 11:30 Hrs [IST] Intuitive, a global technology ...